Related Experiment Video
Updated: Aug 10, 2026

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
Published on: March 5, 2019
Rho family-associated kinases PAK1 and rock
Hiroshi Maruta1, Thao V Nheu, Hong He
1Ludwig Institute for Cancer Research, PO Box 2008, Royal Melbourne Hospital, Parkville/Melbourne, Australia 3050.
Abstract:
Rho family GTPases (Rho, Rac and CDC42) share around 30% sequence identity with RAS family GTPases, and are essential for RAS-induced malignant transformation, i.e., aberrant serum/anchorage-independent growth and actin cytoskeleton-linked morphological changes. Oncogenic RAS mutants such as v-Ha-RAS trigger cell cycle entry (G0-G1 transition) mainly by up-regulating cyclin D1, an activator of cyclin-dependent kinases (CDK), and down-regulating p27, a CDK inhibitor. Although both Rac and CDC42 are clearly activated by RAS, there is so far no evidence that RAS activates Rho. In this chapter, we will discuss the role of these Rho family GTPases and their effectors, in particular the Ser/Thr kinases PAK1 and Rock, in RAS-induced serum/anchorage-independent cell cycling, and discuss several potential therapeutics, peptides or chemical compounds, that could block this oncogenic cell cycle signalling pathway.
Insights
RAS-induced malignant transformation involves Rho family GTPases like Rac and CDC42, which promote cell cycle progression. This study explores their role and potential therapeutic targets to block oncogenic signaling.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Rho family GTPases (Rho, Rac, CDC42) are homologous to RAS GTPases.
- RAS-induced malignant transformation involves aberrant cell growth and morphological changes.
- Oncogenic RAS mutants up-regulate cyclin D1 and down-regulate p27, promoting cell cycle entry.
Purpose of the Study:
- To discuss the role of Rho family GTPases and their effectors in RAS-induced cell cycling.
- To explore potential therapeutic strategies targeting this pathway.
Main Methods:
- Review of existing literature on Rho GTPases, RAS signaling, and cell cycle regulation.
- Analysis of the involvement of PAK1 and Rock kinases in RAS-mediated transformation.
Main Results:
- Rac and CDC42 are activated by RAS, contributing to malignant transformation.
- Rho GTPases and their effectors (PAK1, Rock) are key in RAS-induced serum/anchorage-independent cell cycling.
- RAS does not appear to activate Rho directly.
Conclusions:
- Rho family GTPases play a critical role in RAS-induced oncogenic cell cycling.
- Targeting these GTPases or their downstream effectors presents potential therapeutic avenues for cancer treatment.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Receptor Tyrosine Kinases
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway

